Updated on 28 October 2014
The annual vaccine procurement budget in Thailand has increased annually to $157.5 million, in 2013
Singapore: Thailand has the potential to become ASEAN's vaccine hub, said the country's National Vaccine Institute (NVI) director, Mr Charung Muangchana.
Speaking recently to a news daily, he said that Thailand's high caliber researchers and vaccine developers can effectively strengthen the country's research and development enabling Thailand become Asia's huge vaccine supplier.
Mr Muangchana said that many vaccine projects in Thailand were shelved in the past due to certain issues with law and decision-making, which hampered vaccine development in the country.
He added that the annual vaccine procurement budget from both public and private sectors in Thailand had increased annually to $157.5 million, in 2013.
Thailand had recently hosted the ASEAN vaccine conference in Phuket, to propose for co-operation and strengthen the region's vaccine market. Mr Muangchana added that the country should add necessary vaccines like rotavirus-triggered diarrhoea or hepatitis A, dengue fever and human papillomavirus (HPV) in the nation's immunization plan.